secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2024-02-12T23:59:59+00:00
Accession:  0001437749-24-003763
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integrated BioPharma Q2 revenue down 6.5% to $11.5M; net loss widens to $0.4M
-----------------------------------------------------------------------------

- Revenue $11.5M vs $12.3M in prior-year quarter (-6.5%).
- Operating loss of ~$0.5M vs ~$33K loss a year ago.
- Net loss of $0.4M ($0.01 per share) vs $3K loss ($0.00) prior year.
- Six-month revenue $24.4M vs $24.6M; net loss $0.4M vs $0.1M.
- Two largest customers represent ~90% of total revenue; company aims to diversify by FY2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774924003763/0001437749-24-003763-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774924003763/inbp20240209_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-003763

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer